Paper36099298
Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Acinetobacter baumannii.
Huang KJ and 18 others. Proc Natl Acad Sci U S A, 2022. Cited by 18 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Acinetobacter baumannii. Papers, record 36099298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36099298
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Acinetobacter baumannii.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acinetobacter baumannii | Major topic |
| Anti-Bacterial Agents | Major topic |
| Aspartic Acid Endopeptidases | Major topic |
| Bacterial Proteins | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Furans | Major topic |
| Gene Deletion | Major topic |
| Lipoproteins | Major topic |
| Protease Inhibitors | Major topic |
| Pyridines | Major topic |
| Peptides | |
| Protein Sorting Signals |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,048,314 | Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/7048314 | PubMed |
| 2 | 24,696,435 | OXA β-lactamases. | Clin Microbiol Rev | 2014 | https://conductscience.org/library/papers/24696435 | PubMed |
| 3 | 25,516,853 | Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. | World J Clin Cases | 2014 | https://conductscience.org/library/papers/25516853 | PubMed |
| 4 | 28,489,819 | Predictive compound accumulation rules yield a broad-spectrum antibiotic. | Nature | 2017 | https://conductscience.org/library/papers/28489819 | PubMed |
| 5 | 26,373,371 | Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. | Nat Rev Microbiol | 2015 | https://conductscience.org/library/papers/26373371 | PubMed |
| 6 | 1,855,987 | Sequence and structural analysis of surface protein antigen I/II (SpaA) of Streptococcus sobrinus. | Infect Immun | 1991 | https://conductscience.org/library/papers/1855987 | PubMed |
| 7 | 9,144,772 | Identification of a novel bond between a histidine and the essential tyrosine in catalase HPII of Escherichia coli. | Protein Sci | 1997 | https://conductscience.org/library/papers/9144772 | PubMed |
| 8 | 323,852 | On the process of cellular division in Escherichia coli: a mutant of E. coli lacking a murein-lipoprotein. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/323852 | PubMed |
| 9 | 3,284,654 | A single amino acid determinant of the membrane localization of lipoproteins in E. coli. | Cell | 1988 | https://conductscience.org/library/papers/3284654 | PubMed |
| 10 | 16,585,737 | A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. | J Bacteriol | 2006 | https://conductscience.org/library/papers/16585737 | PubMed |
| 11 | 368,071 | Subunit structure of functional porin oligomers that form permeability channels in the other membrane of Escherichia coli. | J Biol Chem | 1979 | https://conductscience.org/library/papers/368071 | PubMed |
| 12 | 4,745,422 | Chemical analysis of the outer membrane and other layers of the cell envelope of Acinetobacter sp. | J Bacteriol | 1973 | https://conductscience.org/library/papers/4745422 | PubMed |
| 13 | 17,350,956 | Amino acids at positions 3 and 4 determine the membrane specificity of Pseudomonas aeruginosa lipoproteins. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17350956 | PubMed |
| 14 | 14,964,402 | Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations. | New Microbiol | 2004 | https://conductscience.org/library/papers/14964402 | PubMed |
| 15 | 28,348,979 | Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. | Front Cell Infect Microbiol | 2017 | https://conductscience.org/library/papers/28348979 | PubMed |
| 16 | 6,313,621 | Outer membrane protein K of Escherichia coli: purification and pore-forming properties in lipid bilayer membranes. | J Bacteriol | 1983 | https://conductscience.org/library/papers/6313621 | PubMed |
| 17 | 24,098,145 | The serum resistome of a globally disseminated multidrug resistant uropathogenic Escherichia coli clone. | PLoS Genet | 2013 | https://conductscience.org/library/papers/24098145 | PubMed |
| 18 | 4,918,558 | The murein-lipoprotein linkage in the cell wall of Escherichia coli. | Eur J Biochem | 1970 | https://conductscience.org/library/papers/4918558 | PubMed |
| 19 | 33,667,939 | Lipoproteins in Gram-negative bacteria: new insights into their biogenesis, subcellular targeting and functional roles. | Curr Opin Microbiol | 2021 | https://conductscience.org/library/papers/33667939 | PubMed |
| 20 | 20,974,828 | Lipoproteins of bacterial pathogens. | Infect Immun | 2011 | https://conductscience.org/library/papers/20974828 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,736,309 | Mechanistic basis of LolDF-mediated lipoprotein transport in Acinetobacter. | Nat Commun | 2026 | https://conductscience.org/library/papers/42736309 | PubMed |
| 42,470,394 | Random Forest Modeling to Predict Small Molecule Accumulation in Gram-Negative Bacteria. | ACS Infect Dis | 2026 | https://conductscience.org/library/papers/42470394 | PubMed |
| 41,851,483 | Periplasmic crowding and peptidoglycan hydrolase activity as drivers of outer membrane vesiculation in Acinetobacter baumannii. | Commun Biol | 2026 | https://conductscience.org/library/papers/41851483 | PubMed |
| 41,678,533 | Identification of multiple Acinetobacter baumannii protein antigens as targets for potential immunotherapies using a novel protein microarray screening approach. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/41678533 | PubMed |
| 41,570,074 | A surface-exposed cardiolipin synthase provides an unexpected paradigm for maintaining the Gram-negative outer membrane. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41570074 | PubMed |
| 41,400,389 | The type II secretion system utilizes GspN for transport of lipoproteins to the Acinetobacter baumannii cell surface. | mBio | 2026 | https://conductscience.org/library/papers/41400389 | PubMed |
| 40,964,375 | The Type II Secretion System Utilizes AsmA-like Protein GspN to Facilitate Transport of Lipoproteins to the Cell Surface in Acinetobacter baumannii. | bioRxiv | 2025 | https://conductscience.org/library/papers/40964375 | PubMed |
| 40,940,670 | Metabolic Tagging Reveals Surface-Associated Lipoproteins in Mycobacteria. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/40940670 | PubMed |
| 40,148,602 | Global health perspectives on antibacterial drug discovery and the preclinical pipeline. | Nat Rev Microbiol | 2025 | https://conductscience.org/library/papers/40148602 | PubMed |
| 39,670,753 | Outer membrane lipoproteins: late to the party, but the center of attention. | J Bacteriol | 2025 | https://conductscience.org/library/papers/39670753 | PubMed |
| 39,660,887 | The BfmRS stress response protects Acinetobacter baumannii against defects in outer membrane lipoprotein biogenesis. | J Bacteriol | 2025 | https://conductscience.org/library/papers/39660887 | PubMed |
| 38,712,757 | Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase. | ACS Chem Biol | 2024 | https://conductscience.org/library/papers/38712757 | PubMed |
| 38,426,413 | Using permeation guidelines to design new antibiotics-A PASsagE into Pseudomonas aeruginosa. | Clin Transl Med | 2024 | https://conductscience.org/library/papers/38426413 | PubMed |
| 38,193,657 | Genetic analysis reveals a robust and hierarchical recruitment of the LolA chaperone to the LolCDE lipoprotein transporter. | mBio | 2024 | https://conductscience.org/library/papers/38193657 | PubMed |
| 37,993,720 | Porin-independent accumulation in Pseudomonas enables antibiotic discovery. | Nature | 2023 | https://conductscience.org/library/papers/37993720 | PubMed |
| 37,986,794 | Genetic analysis reveals a robust and hierarchical recruitment of the LolA chaperone to the LolCDE lipoprotein transporter. | bioRxiv | 2023 | https://conductscience.org/library/papers/37986794 | PubMed |
| 37,390,210 | Structure snapshots reveal the mechanism of a bacterial membrane lipoprotein N-acyltransferase. | Sci Adv | 2023 | https://conductscience.org/library/papers/37390210 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36099298
GET https://conductscience.org/api/papers/v1/36099298/references?page=2